Is Nonalcoholic Fatty Liver Disease in Children the Same Disease as in Adults?

Clinics in Liver Disease

Volumn 16, Issue 3, 2012, Pages 587-598

  Hsu, Evelyn ^a   Murray, Karen ^a  

^a SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

Adolescents; Children; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis

Indexed keywords

ADIPONUTRIN; ALPHA TOCOPHEROL; CARNITINE PALMITOYLTRANSFERASE I; GLUCOKINASE REGULATORY PROTEIN; METFORMIN; PATATIN LIKE PHOSPHOLIPASE 3; PHOSPHOLIPASE; PIOGLITAZONE; PLACEBO; PROTEIN; UNCLASSIFIED DRUG;

BODY MASS; DYSLIPIDEMIA; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PATHOPHYSIOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; CHILD; CHRONIC DISEASE; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; QUALITY OF LIFE; YOUNG ADULT;

EID: 84864092610     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2012.05.004     Document Type: Review

References (56)

1. Ludwig J., Viggiano T.R., McGill D.B., et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980, 55(7):434-438.
2. Moran J.R., Ghishan F.K., Halter S.A., et al. Steatohepatitis in obese children: a cause of chronic liver dysfunction. Am J Gastroenterol 1983, 78(6):374-377.
3. Ogden C.L., Carroll M.D., Kit B.K., et al. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA 2012, 307(5):483-490.
4. Flegal K.M., Carroll M.D., Kit B.K., et al. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012, 307(5):491-497.
5. Strauss R.S., Barlow S.E., Dietz W.H. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr 2000, 136(6):727-733.
6. Nadeau K.J., Klingensmith G., Zeitler P. Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. J Pediatr Gastroenterol Nutr 2005, 41(1):94-98.
7. Neuschwander-Tetri B.A., Clark J.M., Bass N.M., et al. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology 2010, 52(3):913-924.
8. Saverymuttu S.H., Joseph A.E., Maxwell J.D. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 1986, 292(6512):13-15.
9. Franzese A., Vajro P., Argenziano A., et al. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 1997, 42(7):1428-1432.
10. Tominaga K., Kurata J.H., Chen Y.K., et al. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci 1995, 40(9):2002-2009.
11. Chan D.F., Li A.M., Chu W.C., et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord 2004, 28(10):1257-1263.
12. Fishbein M., Castro F., Cheruku S., et al. Hepatic MRI for fat quantitation: its relationship to fat morphology, diagnosis, and ultrasound. J Clin Gastroenterol 2005, 39(7):619-625.
13. Schwimmer J.B., Deutsch R., Kahen T., et al. Prevalence of fatty liver in children and adolescents. Pediatrics 2006, 118(4):1388-1393.
14. Wanless I.R., Lentz J.S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990, 12(5):1106-1110.
15. Schwimmer J.B., McGreal N., Deutsch R., et al. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics 2005, 115(5):e561-e565.
16. Bambha K., Belt P., Abraham M., et al. Ethnicity and nonalcoholic fatty liver disease. Hepatology 2012, 55(3):769-780.
17. Patton H.M., Yates K., Unalp-Arida A., et al. Association between metabolic syndrome and liver histology among children with nonalcoholic fatty liver disease. Am J Gastroenterol 2010, 105(9):2093-2102.
18. Schwimmer J. Non-alcoholic fatty liver disease. Liver disease in children 2007, 830-839. Cambridge University Press. 3rd edition. F. Suchy, W. Balistreri (Eds.).
19. Lavine J.E., Schwimmer J.B. Pediatric initiatives within the Nonalcoholic Steatohepatitis-Clinical Research Network (NASH CNR). J Pediatr Gastroenterol Nutr 2003, 37(3):220-221.
20. Romeo S., Kozlitina J., Xing C., et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008, 40(12):1461-1465.
21. Kotronen A., Johansson L.E., Johansson L.M., et al. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia 2009, 52(6):1056-1060.
22. Romeo S., Sentinelli F., Dash S., et al. Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent. Int J Obes (Lond) 2010, 34(1):190-194.
23. Speliotes E.K., Butler J.L., Palmer C.D., et al. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. Hepatology 2010, 52(3):904-912.
24. Santoro N., Kursawe R., D'Adamo E., et al. A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. Hepatology 2010, 52(4):1281-1290.
25. Valenti L., Alisi A., Galmozzi E., et al. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology 2010, 52(4):1274-1280.
26. Romeo S., Sentinelli F., Cambuli V.M., et al. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life. J Hepatol 2010, 53(2):335-338.
27. Valenti L., Alisi A., Nobili V. Unraveling the genetics of fatty liver in obese children: additive effect of P446L GCKR and I148M PNPLA3 polymorphisms. Hepatology 2012, 55(3):661-663.
28. Santoro N., Zhang C.K., Zhao H., et al. Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents. Hepatology 2012, 55(3):781-789.
29. Petersen K.F., Dufour S., Hariri A., et al. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med 2010, 362(12):1082-1089.
30. Lee R.G. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol 1989, 20(6):594-598.
31. Molleston J.P., White F., Teckman J., et al. Obese children with steatohepatitis can develop cirrhosis in childhood. Am J Gastroenterol 2002, 97(9):2460-2462.
32. Rashid M., Roberts E.A. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 2000, 30(1):48-53.
33. Jonas M.M., Krawczuk L.E., Kim H.B., et al. Rapid recurrence of nonalcoholic fatty liver disease after transplantation in a child with hypopituitarism and hepatopulmonary syndrome. Liver Transpl 2005, 11(1):108-110.
34. Jankowska I., Socha P., Pawlowska J., et al. Recurrence of non-alcoholic steatohepatitis after liver transplantation in a 13-yr-old boy. Pediatr Transplant 2007, 11(7):796-798.
35. Feldstein A.E., Charatcharoenwitthaya P., Treeprasertsuk S., et al. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 2009, 58(11):1538-1544.
36. Baffy G., Brunt E.M., Caldwell S.H. Hepatocellular carcinoma in nonalcoholic fatty liver disease: an emerging menace. J Hepatol 2012, 56(6):1384-1391.
37. Cuadrado A., Orive A., Garcia-Suarez C., et al. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma. Obes Surg 2005, 15(3):442-446.
38. Kistler K.D., Molleston J., Unalp A., et al. Symptoms and quality of life in obese children and adolescents with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2010, 31(3):396-406.
39. Lavine J.E., Schwimmer J.B., Van Natta M.L., et al. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA 2011, 305(16):1659-1668.
40. Skelly M.M., James P.D., Ryder S.D. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. J Hepatol 2001, 35(2):195-199.
41. Schwimmer J.B., Behling C., Newbury R., et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 2005, 42(3):641-649.
42. Brunt E.M. Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 2010, 7(4):195-203.
43. Kleiner D.E., Brunt E.M., Van Natta M., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41(6):1313-1321.
44. Abrams G.A., Kunde S.S., Lazenby A.J., et al. Portal fibrosis and hepatic steatosis in morbidly obese subjects: a spectrum of nonalcoholic fatty liver disease. Hepatology 2004, 40(2):475-483.
45. Carter-Kent C., Yerian L.M., Brunt E.M., et al. Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study. Hepatology 2009, 50(4):1113-1120.
46. Vos M.B., Colvin R., Belt P., et al. Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD. J Pediatr Gastroenterol Nutr 2012, 54(1):90-96.
47. Belfort R., Harrison S.A., Brown K., et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med 2006, 355(22):2297-2307.
48. Promrat K., Lutchman G., Uwaifo G.I., et al. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology 2004, 39(1):188-196.
49. Sanyal A.J., Mofrad P.S., Contos M.J., et al. A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 2004, 2(12):1107-1115.
50. Harrison S.A., Torgerson S., Hayashi P., et al. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2003, 98(11):2485-2490.
51. Sanyal A.J., Chalasani N., Kowdley K.V., et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010, 362(18):1675-1685.
52. Lavine J.E. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr 2000, 136(6):734-738.
53. Schwimmer J.B., Middleton M.S., Deutsch R., et al. A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2005, 21(7):871-879.
54. Promrat K., Kleiner D.E., Niemeier H.M., et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010, 51(1):121-129.
55. Vajro P., Fontanella A., Perna C., et al. Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr 1994, 125(2):239-241.
56. Nobili V., Manco M., Devito R., et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 2008, 48(1):119-128.